Mahesh N Desai

Title: Mahesh N Desai: Innovator in Pharmaceutical Composition

Introduction

Mahesh N Desai is a notable inventor based in Clifton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective antagonists for the NPY (Y5) receptor. With a total of 3 patents to his name, Desai's work has the potential to impact therapeutic treatments significantly.

Latest Patents

Desai's latest patents focus on selective NPY (Y5) antagonists. One of his inventions is directed to triazine derivatives, bicyclic compounds, and tricyclic compounds that act as selective antagonists for the NPY (Y5) receptor. This invention provides a pharmaceutical composition that includes a therapeutically effective amount of a compound and a pharmaceutically acceptable carrier. Additionally, he has developed a process for creating a pharmaceutical composition that combines these compounds with a suitable carrier. His work aims to prepare pharmaceutical compositions for treating abnormalities by decreasing the activity of the human Y5 receptor.

Career Highlights

Throughout his career, Mahesh N Desai has worked with prominent companies in the pharmaceutical industry, including Synaptic Pharmaceutical Corporation and H. Lundbeck A/S. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Desai has collaborated with notable professionals in his field, including Mohammad R Marzabadi and Stewart Alwyn Noble. These collaborations have likely enriched his research and development efforts.

Conclusion

Mahesh N Desai is a distinguished inventor whose work in pharmaceutical compositions has the potential to advance medical treatments. His innovative approach to developing selective NPY (Y5) antagonists showcases his commitment to improving healthcare solutions.